1. AB0384 MEDICATION USE IN SYSTEMIC LUPUS ERYTHEMATOSUS – DATA FROM A MULTICENTRE COHORT STUDY. (2nd June 2020) Authors: Kandane-Rathnayake, R.; Louthrenoo, W.; Luo, S. F.; Wu, Y. J.; Chen, Y. H.; Golder, V.; Lateef, A.; Cho, J.; Navarra, S.; Zamora, L.; Hamijoyo, L.; Sockalingam, S.; An, Y.; Li, Z.; Katsumata, Y.; Harigai, M.; Hao, Y.; Zhang, Z.; Chan, M.; Kikuchi, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0398 Disease Specific Quality of Life in Patients with Lupus Nephritis. (10th June 2014) Authors: Jolly, M.; Toloza, S.; Bertoli, A.; Blazevic, I.; Vila, L.; Moldovan, I.; Torralba, K.; Kaya, A.; Goker, B.; Tezcan, M.; Haznedaroglu, S.; Bourre-Tessier, J.; Navarra, S.; Wallace, D.; Weisman, M.; Clarke, A.; Alarcon, G.; Mok, C.C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study. (23rd January 2014) Authors: Yoo, D. H.; Racewicz, A.; Brzezicki, J.; Yatsyshyn, R.; Tobias Arteaga, E.; Baranauskaite, A.; Abud-Mendoza, C.; Navarra, S.; Eullaran, R.; Kadinov, V.; Goecke Sariego, I.; Byrne, P.; Park, W.; Lee, S. J.; Kim, H. U.; Müller-Ladner, U. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0092 Remission in Sle: Consensus Findings from a Large International Panel on Definitions of Remission in SLE (DORIS). (9th June 2015) Authors: van Vollenhoven, R.F.; Aranow, C.; Bertsias, G.; Bonfá, E.; Cervera, R.; Costedoat-Chalumeau, N.; Dörner, T.; Houssiau, F.; Lerstrom, K.; Morand, E.; Mosca, M.; Navarra, S.; Petri, M.; Urowitz, M.; Voskuijl, A.; Voss, A.; Ward, M.; Werth, V.; Schneider, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0193 BIIB059, A HUMANIZED MONOCLONAL ANTIBODY TARGETING BDCA2 ON PLASMACYTOID DENDRITIC CELLS (PDC), SHOWS DOSE-RELATED EFFICACY IN THE PHASE 2 LILAC STUDY IN PATIENTS (PTS) WITH ACTIVE CUTANEOUS LUPUS ERYTHEMATOSUS (CLE). (2nd June 2020) Authors: Werth, V.; Furie, R.; Romero-Diaz, J.; Navarra, S.; Kalunian, K.; Van Vollenhoven, R.; Nyberg, F.; Kaffenberger, B.; Sheikh, S.; Radunovic, G.; Huang, X.; Carroll, H.; Gaudreault, F.; Meyers, A.; Barbey, C.; Musselli, C.; Franchimont, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0306 Subcutaneous secukinumab inhibits radiographic progression in psoriatic arthritis: analysis by prior anti-tnf therapy and concomitant methotrexate use. (12th June 2018) Authors: van der Heijde, D.; Mease, P.; Landewé, R.; Mpofu, S.; Rahman, P.; Tahir, H.; Singhal, A.; Boettcher, E.; Navarra, S.; Zhu, X.; Readie, A.; Pricop, L.; Abrams, K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0197 Baseline laboratory characteristics from the combined placebo groups in the bliss trials are predictive of severe flare at 24 weeks. (23rd January 2014) Authors: Petri, M.; van Vollenhoven, R.F.; Levy, R.A.; Navarra, S.; Cervera, R.; Zhong, Z.J.; Freimuth, W.; Buyon, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0204 Predictors for SLE flares: Baseline disease activity and demographic characteristics from the bliss trials' combined placebo groups. (23rd January 2014) Authors: van Vollenhoven, R.F.; Petri, M.; Levy, R.A.; Navarra, S.; Buyon, J.; Zhong, Z.J.; Freimuth, W.; Cervera, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0430 Assessment of acr and slicc classification criteria in the asia pacific lupus collaboration cohort. (12th June 2018) Authors: Kandane-Rathnayake, R.; Golder, V.; Louthrenoo, W.; Luo, S.-F.; Wu, Y.-J.; Lateef, A.; Sockalingam, S.; Navarra, S.; Zamora, L.; Hamijoyo, L.; Katsumata, Y.; Harigai, M.; Chan, M.; O'Neill, S.; Goldblatt, F.; Lau, C.S.; Hoi, A.; Nikpour, M.; Morand, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0304 Adherence To Hydroxychloroquine as Assessed by Measurements of Drug and Metabolite Blood Levels in An International Prospective Study of Sle Patients in Flare. (15th July 2016) Authors: Costedoat-Chalumeau, N.; Houssiau, F.; Izmirly, P.; Le Guern, V.; Navarra, S.; Jolly, M.; Ruiz-Irastorza, G.; Hachulla, E.; Agmon-Levin, N.; Shoenfeld, Y.; Dall'Ara, F.; Buyon, J.; Deligny, C.; Cervera, R.; Lazaro, E.; Bezanahary, H.; Leroux, G.; Morel, N.; Viallard, J.-F.; Pineau, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗